Bank of New York Mellon’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.82M | Buy |
118,597
+7,596
| +7% | +$609K | ﹤0.01% | 2040 |
|
|
2026
Q1 | $8.54M | Sell |
111,001
-1,643
| -1% | -$128K | ﹤0.01% | 2018 |
|
|
2025
Q4 | $8.89M | Sell |
112,644
-3,628
| -3% | -$314K | ﹤0.01% | 1990 |
|
|
2025
Q3 | $10.7M | Sell |
116,272
-2,522
| -2% | -$206K | ﹤0.01% | 1893 |
|
|
2025
Q2 | $7.75M | Sell |
118,794
-468
| -0.4% | -$30.5K | ﹤0.01% | 2033 |
|
|
2025
Q1 | $7.98M | Sell |
119,262
-4,570
| -4% | -$273K | ﹤0.01% | 1972 |
|
|
2024
Q4 | $6.85M | Buy |
123,832
+4,404
| +4% | +$253K | ﹤0.01% | 2130 |
|
|
2024
Q3 | $7.13M | Sell |
119,428
-11,728
| -9% | -$715K | ﹤0.01% | 2108 |
|
|
2024
Q2 | $8.35M | Buy |
131,156
+12,865
| +11% | +$835K | ﹤0.01% | 2055 |
|
|
2024
Q1 | $8.18M | Sell |
118,291
-7,860
| -6% | -$474K | ﹤0.01% | 2061 |
|
|
2023
Q4 | $6.96M | Buy |
126,151
+2,434
| +2% | +$134K | ﹤0.01% | 2202 |
|
|
2023
Q3 | $7.18M | Buy |
123,717
+10,234
| +9% | +$591K | ﹤0.01% | 2137 |
|
|
2023
Q2 | $6.11M | Buy |
113,483
+3,994
| +4% | +$177K | ﹤0.01% | 2213 |
|
|
2023
Q1 | $4.35M | Sell |
109,489
-4,608
| -4% | -$194K | ﹤0.01% | 2383 |
|
|
2022
Q4 | $4.59M | Sell |
114,097
-6,537
| -5% | -$246K | ﹤0.01% | 2387 |
|
|
2022
Q3 | $3.88M | Sell |
120,634
-550
| -0.5% | -$18.8K | ﹤0.01% | 2436 |
|
|
2022
Q2 | $3.6M | Sell |
121,184
-1,902
| -2% | -$54.9K | ﹤0.01% | 2494 |
|
|
2022
Q1 | $3.46M | Sell |
123,086
-18,293
| -13% | -$682K | ﹤0.01% | 2624 |
|
|
2021
Q4 | $6.51M | Buy |
141,379
+45,477
| +47% | +$1.95M | ﹤0.01% | 2327 |
|
|
2021
Q3 | $3.15M | Buy |
95,902
+2,052
| +2% | +$63.8K | ﹤0.01% | 2743 |
|
|
2021
Q2 | $3.29M | Sell |
93,850
-7,029
| -7% | -$239K | ﹤0.01% | 2696 |
|
|
2021
Q1 | $3.65M | Sell |
100,879
-2,857
| -3% | -$89.5K | ﹤0.01% | 2602 |
|
|
2020
Q4 | $3.01M | Sell |
103,736
-5,425
| -5% | -$155K | ﹤0.01% | 2608 |
|
|
2020
Q3 | $3.08M | Buy |
109,161
+3,642
| +3% | +$108K | ﹤0.01% | 2445 |
|
|
2020
Q2 | $3.41M | Buy |
105,519
+850
| +0.8% | +$30.5K | ﹤0.01% | 2403 |
|
|
2020
Q1 | $4.26M | Sell |
104,669
-3,940
| -4% | -$210K | ﹤0.01% | 2153 |
|
|
2019
Q4 | $6.7M | Sell |
108,609
-325
| -0.3% | -$21.5K | ﹤0.01% | 2185 |
|
|
2019
Q3 | $7.94M | Sell |
108,934
-329
| -0.3% | -$24.6K | ﹤0.01% | 2050 |
|
|
2019
Q2 | $8.98M | Buy |
109,263
+4,442
| +4% | +$316K | ﹤0.01% | 2016 |
|
|
2019
Q1 | $7.39M | Sell |
104,821
-29,768
| -22% | -$1.75M | ﹤0.01% | 2130 |
|
|
2018
Q4 | $6.06M | Buy |
134,589
+474
| +0.4% | +$24.8K | ﹤0.01% | 2183 |
|
|
2018
Q3 | $7.58M | Sell |
134,115
-1,442
| -1% | -$88.2K | ﹤0.01% | 2185 |
|
|
2018
Q2 | $9.06M | Buy |
135,557
+6,262
| +5% | +$391K | ﹤0.01% | 2069 |
|
|
2018
Q1 | $7.53M | Sell |
129,295
-62,147
| -32% | -$3.94M | ﹤0.01% | 2139 |
|
|
2017
Q4 | $12.3M | Buy |
191,442
+34,577
| +22% | +$2.15M | ﹤0.01% | 1890 |
|
|
2017
Q3 | $8.23M | Buy |
156,865
+30,632
| +24% | +$1.46M | ﹤0.01% | 2080 |
|
|
2017
Q2 | $5.91M | Sell |
126,233
-16,281
| -11% | -$785K | ﹤0.01% | 2252 |
|
|
2017
Q1 | $7.06M | Sell |
142,514
-20,840
| -13% | -$1.17M | ﹤0.01% | 2155 |
|
|
2016
Q4 | $9.9M | Sell |
163,354
-30,181
| -16% | -$1.85M | ﹤0.01% | 1967 |
|
|
2016
Q3 | $12.8M | Buy |
193,535
+73,728
| +62% | +$4.61M | ﹤0.01% | 1736 |
|
|
2016
Q2 | $6.69M | Sell |
119,807
-5,416
| -4% | -$263K | ﹤0.01% | 2057 |
|
|
2016
Q1 | $4.22M | Buy |
125,223
+8,730
| +7% | +$296K | ﹤0.01% | 2262 |
|
|
2015
Q4 | $5.26M | Buy |
116,493
+12,440
| +12% | +$535K | ﹤0.01% | 2184 |
|
|
2015
Q3 | $4.11M | Buy |
104,053
+23,081
| +29% | +$1.31M | ﹤0.01% | 2346 |
|
|
2015
Q2 | $5.02M | Buy |
80,972
+12,512
| +18% | +$745K | ﹤0.01% | 2354 |
|
|
2015
Q1 | $4.28M | Buy |
68,460
+23,120
| +51% | +$1.41M | ﹤0.01% | 2394 |
|
|
2014
Q4 | $2.56M | Buy |
45,340
+14,848
| +49% | +$655K | ﹤0.01% | 2696 |
|
|
2014
Q3 | $863K | Buy |
30,492
+3,003
| +11% | +$90K | ﹤0.01% | 3377 |
|
|
2014
Q2 | $946K | Buy |
+27,489
| New | +$862K | ﹤0.01% | 3344 |
|
Other funds holding ANIP
SCM
N
Bank of New York Mellon's ANIP Position: Q2 2026 in Review
Bank of New York Mellon increased its ANI Pharmaceuticals (ANIP) stake by 6.8% in Q2 2026, buying an estimated $609K and bringing the position to 118,597 shares worth $9.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2040.
Bank of New York Mellon first reported a position in ANIP in Q2 2014 and has held it in 49 quarters since. The position peaked at $12.8M in Q3 2016. 172 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.
- Bank of New York Mellon held 118,597 shares of ANI Pharmaceuticals worth $9.82M as of Q2 2026.
- Bank of New York Mellon bought 7,596 ANI Pharmaceuticals shares in Q2 2026, an estimated $609K.
- ANI Pharmaceuticals made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2040 holding.
- Bank of New York Mellon first reported a position in ANI Pharmaceuticals in Q2 2014 and has held it in 49 quarters since.
- Bank of New York Mellon's ANI Pharmaceuticals position peaked at $12.8M in Q3 2016.
- 172 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.